591 related articles for article (PubMed ID: 15199476)
1. Orally active direct thrombin inhibitors.
Weitz J
Semin Vasc Med; 2003 May; 3(2):131-8. PubMed ID: 15199476
[TBL] [Abstract][Full Text] [Related]
2. Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation.
Halperin JL
J Am Coll Cardiol; 2005 Jan; 45(1):1-9. PubMed ID: 15629364
[TBL] [Abstract][Full Text] [Related]
3. Ximelagatran: a new oral anticoagulant.
Hrebickova L; Nawarskas JJ; Anderson JR
Heart Dis; 2003; 5(6):397-408. PubMed ID: 14633322
[TBL] [Abstract][Full Text] [Related]
4. Ximelagatran: a novel oral direct thrombin inhibitor for long-term anticoagulation.
McCullough PA; Dorrell KA; Sandberg KR; Yerkey MW
Rev Cardiovasc Med; 2004; 5(2):99-103. PubMed ID: 15184843
[TBL] [Abstract][Full Text] [Related]
5. Ximelagatran: a new oral anticoagulant.
Francis CW
Best Pract Res Clin Haematol; 2004 Mar; 17(1):139-52. PubMed ID: 15171963
[TBL] [Abstract][Full Text] [Related]
6. Clinical trials of new anticoagulants.
Anderson J; O'Donnell M
Vnitr Lek; 2006 Mar; 52 Suppl 1():123-6. PubMed ID: 16637460
[TBL] [Abstract][Full Text] [Related]
7. Ximelagatran: pharmacokinetics and pharmacodynamics of a new strategy for oral direct thrombin inhibition.
Kereiakes DJ
Rev Cardiovasc Med; 2004; 5 Suppl 5():S4-11. PubMed ID: 15619615
[TBL] [Abstract][Full Text] [Related]
8. New anticoagulants for treatment of venous thromboembolism.
Weitz JI
Circulation; 2004 Aug; 110(9 Suppl 1):I19-26. PubMed ID: 15339877
[TBL] [Abstract][Full Text] [Related]
9. A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era..
Mohapatra R; Tran M; Gore JM; Spencer FA
Am Heart J; 2005 Jul; 150(1):19-26. PubMed ID: 16084146
[TBL] [Abstract][Full Text] [Related]
10. Oral direct thrombin inhibitors in clinical development.
Gustafsson D
J Intern Med; 2003 Oct; 254(4):322-34. PubMed ID: 12974871
[TBL] [Abstract][Full Text] [Related]
11. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
Martí-Fàbregas J; Mateo J
Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of ximelagatran.
Wolzt M; Sarich TS; Eriksson UG
Semin Vasc Med; 2005 Aug; 5(3):245-53. PubMed ID: 16123911
[TBL] [Abstract][Full Text] [Related]
13. Ximelagatran for stroke prevention in atrial fibrillation.
Boos CJ; Lip GY
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):551-63. PubMed ID: 16076267
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of the oral direct thrombin inhibitor ximelagatran.
Mattsson C; Sarich TC; Carlsson SC
Semin Vasc Med; 2005 Aug; 5(3):235-44. PubMed ID: 16123910
[TBL] [Abstract][Full Text] [Related]
15. New oral anticoagulants in development.
Weitz JI
Thromb Haemost; 2010 Jan; 103(1):62-70. PubMed ID: 20062934
[TBL] [Abstract][Full Text] [Related]
16. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
17. Low potential for interactions between melagatran/ximelagatran and other drugs, food, or alcohol.
Wolzt M; Sarich TS; Eriksson UG
Semin Vasc Med; 2005 Aug; 5(3):254-8. PubMed ID: 16123912
[TBL] [Abstract][Full Text] [Related]
18. [New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins].
Scardi S; Giansante C
Ital Heart J Suppl; 2004 Sep; 5(9):705-11. PubMed ID: 15568608
[TBL] [Abstract][Full Text] [Related]
19. New anticoagulants for atrial fibrillation.
De Caterina R; Kristensen SD; Renda G
J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
[TBL] [Abstract][Full Text] [Related]
20. Ximelagatran--a promising new drug in thromboembolic disorders.
Petersen P
Curr Pharm Des; 2005; 11(4):527-38. PubMed ID: 15725069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
